AI Revives Old Diabetes Drug to Fight Deadly Superbugs

AI has helped revive Halicin, a discontinued diabetes drug, as a potential weapon against deadly antibiotic-resistant superbugs. A new study found it effective against 94% of tested bacteria, offering hope in the global fight against infections like MRSA and pneumonia. Further research is needed before clinical use, but the breakthrough highlights AI’s growing role in medical discovery.